• DOI:10.1161/CIR.0000000000000228
• Corpus ID: 8548491

Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association

@article{Havranek2015SocialDO,
  title={Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association},
  author={Edward P. Havranek and Mahasin S. Mujahid and Donald A. Barr and Irene V. Blair and Meryl S. Cohen and Salvador Cruz-Flores and George Davey-Smith and Cheryl Renee Dennison-Himmelfarb and Michael S. Lauer and Debra W. Lockwood and Milagros C. Rosal and Clyde W. Yancy},
  journal={Circulation},
  year={2015},
  volume={132},
  pages={873–898}
}

• E. Havranek, M. Mujahid, +9 authors C. Yancy
• Published 1 September 2015
• Medicine
• Circulation

An Institute of Medicine report titled U.S. Health in International Perspective: Shorter Lives, Poorer Health documents the decline in the health status of Americans relative to people in other high-income countries, concluding that “Americans are dying and suffering from illness and injury at rates that are demonstrably unnecessary.”1 The report blames many factors, “adverse economic and social conditions” among them. In an editorial in Science discussing the findings of the Institute of Medicine report, Bayer et al2 call for a national commission on health “to address the social causes that have put the USA last among comparable nations.”

Although mortality from cardiovascular disease (CVD) in the United States has been on a linear decline since the 1970s, the burden remains high. It accounted for 31.9% of deaths in 2010.3

There is general agreement that the decline is the result, in equal measure, of advances in prevention and advances in treatment. These advances in turn rest on dramatic successes in efforts to understand the biology of CVD that began in the late 1940s.4,5 It has been assumed that the steady downward trend in mortality will continue into the future as further breakthroughs in biological science lead to further advances in prevention and treatment. This view of the future may not be warranted.

The prevalence of CVD in the United States is expected to rise 10% between 2010 and 2030.6 This change in the trajectory of cardiovascular burden is the result not only of an aging population but also of a dramatic rise over the past 25 years in obesity and the hypertension, diabetes mellitus, and physical inactivity that accompany weight gain. Although there is no consensus on the precise causes of the obesity epidemic, a dramatic change in the underlying biology of Americans is …